Pilot study: volatile organic compounds as a diagnostic marker for head and neck tumors.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 18286484.
- Also identified by DOI 10.1002/hed.20779.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the last decade, the analysis of volatile organic compounds (VOC) has undergone a rapid development. In this pilot study, patients with HNSCC were tested with a proton transfer reaction-mass spectrometry in order to establish a minimal invasive screening method. Overall in a period of 2 years, 22 carcinoma patients were recruited for the study. All patients had a newly diagnosed histologically secured squamous cell carcinoma of the upper aerodigestive tract. These results were statistically compared with 3 control groups: healthy controls, high-risk, and posttherapy patients. Two hundred nine different masses were measured; 188 of these were evaluated. The statistical workup of the 4 study groups produced 42 different masses, which showed a statistically significant difference from the carcinoma group compared with the control groups. A screening method for HNSCC using VOC seems to be possible, but further investigation is necessary.
Medical subject headings
- Carcinoma, Squamous Cell
- Head and Neck Neoplasms
- Organic Chemicals